Condor Capital Management’s GSK GSK Stock Holding History

Condor Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,652	Closed	-$748K	–	415
2021 Q3	$748K	Hold	15,652	–	–	0.08%	155
2021 Q2	$779K	Hold	15,652	–	–	0.09%	149
2021 Q1	$698K	Hold	15,652	–	–	0.08%	146
2020 Q4	$720K	Hold	15,652	–	–	0.09%	141
2020 Q3	$736K	Hold	15,652	–	–	0.11%	137
2020 Q2	$798K	Hold	15,652	–	–	0.12%	130
2020 Q1	$741K	Hold	15,652	–	–	0.14%	125
2019 Q4	$919K	Sell	15,652 -285	-2%	-$15.9K	0.13%	133
2019 Q3	$850K	Sell	15,937 -285	-2%	-$14.7K	0.13%	133
2019 Q2	$811K	Hold	16,222	–	–	0.13%	134
2019 Q1	$847K	Hold	16,222	–	–	0.14%	133
2018 Q4	$775K	Hold	16,222	–	–	0.14%	132
2018 Q3	$815K	Buy	16,222 +2	+0%	+$102	0.15%	125
2018 Q2	$817K	Sell	16,220 -285	-2%	-$14.4K	0.16%	123
2018 Q1	$806K	Hold	16,505	–	–	0.17%	121
2017 Q4	$732K	Hold	16,505	–	–	0.15%	124
2017 Q3	$838K	Hold	16,505	–	–	0.17%	120
2017 Q2	$890K	Hold	16,505	–	–	0.19%	113
2017 Q1	$870K	Hold	16,505	–	–	0.19%	113
2016 Q4	$794K	Hold	16,505	–	–	0.18%	122
2016 Q3	$890K	Sell	16,505 -68	-0.4%	-$3.73K	0.21%	111
2016 Q2	$898K	Hold	16,573	–	–	0.21%	112
2016 Q1	$840K	Hold	16,573	–	–	0.2%	116
2015 Q4	$836K	Hold	16,573	–	–	0.2%	117
2015 Q3	$797K	Hold	16,573	–	–	0.21%	119
2015 Q2	$863K	Sell	16,573 -20	-0.1%	-$1.13K	0.21%	118
2015 Q1	$957K	Buy	+16,593	New	+$951K	0.23%	116

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Condor Capital Management's GSK Position: Q4 2021 in Review

Condor Capital Management sold out of GSK (GSK) in Q4 2021, closing a stake of 15,652 shares — an estimated $748K sold.

Condor Capital Management first reported a position in GSK in Q1 2015 and held it in 27 quarters. The position peaked at $957K in Q1 2015. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

Condor Capital Management reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
Condor Capital Management sold 15,652 GSK shares in Q4 2021, an estimated $748K.
Condor Capital Management first reported a position in GSK in Q1 2015 and held it in 27 quarters.
Condor Capital Management's GSK position peaked at $957K in Q1 2015.
919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Condor Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.